… baumannii clinical isolates have steadily been reported in … showing resistance to tetracycline,
doxycycline and minocycline … of nosocomial meningitis caused by imipenem-resistant A. …

… model, the combination of colistin with minocycline against minocycline-resistant AB strains
… Regarding Acinetobacter baumannii, combination treatment does not appear to provide …

… , rifampin, minocycline, or colistin, have been deployed against MDR A. … in vivo and clinical
studies, of the efficacy of the β-lactam–zidebactam or β-lactam–WCK 5153 combination for …

… Here, we investigated the in vitro activity of antibiotic combinations against carbapenem-…
-resistant ACB is rising worldwide 21 ; fortunately, no colistin-resistant isolate was observed …

… (COL) against clinical isolates of CRE and Acinetobacter spp in Tanta … In vitro activities of
tigecycline,minocycline, … outbreak of imipenemresistant Acinetobacter baumannii by phenotypic …

… treatments, of which colistin-based combination therapy is the … The clonal spread of
imipenem-resistant Acinetobacter spp. … baumannii clinical isolates has the potential to overexpress …

… TGC or aminoglycoside or colistin seems to have … clinical isolates. Moreover, our findings
support the use of high-quality in vitro research to investigate potentially effective combination …

… The efficacy of colistin and ampicillin–sulbactam has not … baumannii. Therefore, the purpose
of this study was to compare efficacy of colistin and ampicillin–sulbactam, in combination …

… Two clinical isolates were used: one with an MIC to … for treatment of imipenem-resistant
Acinetobacter nosocomial … /sulbactam, colistin, and possibly doxycycline or minocycline may be …

… Prior to 2000, only relatively few clinical isolates were … the combination of colistin with
rifampicin against CR A. … Tigecycline is a minocycline derivative belonging to the new class of …